Improved use of antitumoral compound in cancer therapy

Details Improved use of antitumoral compound in cancer therapy Improved use of antitumoral compound in cancer therapy

A - Human Necessities

61

K

A61K 38/00 (2006.01) A61K 31/198 (2006.01) A61K 31/4995 (2006.01) A61K 31/704 (2006.01) A61K 33/24 (2006.01) A61K 38/16 (2006.01) A61K 45/06 (2006.01)

Patent

CA 2462502

Improved dosing schedules for ecteinascidin 743 are given for treatment of cancer.

L'invention concerne des schémas posologiques améliorés pour l'ecteinascidine 743 destinés au traitement de cancer.

Affiliated with

Also associated with

Rating

Improved use of antitumoral compound in cancer therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Improved use of antitumoral compound in cancer therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Improved use of antitumoral compound in cancer therapy will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2081014